Suppr超能文献

COPD 超越近端支气管阻塞:表型与床边相关工具。

COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside.

机构信息

Clinique des Bronches, Allergies et Sommeil, Hôpital Nord, Assistance Publique des Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.

Université de Montpellier, PhyMedExp, INSERM, CNRS, CHU de Montpellier, Dept of Respiratory Diseases, Montpellier, France.

出版信息

Eur Respir Rev. 2019 Jul 8;28(152). doi: 10.1183/16000617.0010-2019. Print 2019 Jun 30.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by nonreversible proximal bronchial obstruction leading to major respiratory disability. However, patient phenotypes better capture the heterogeneously reported complaints and symptoms of COPD. Recent studies provided evidence that classical bronchial obstruction does not properly reflect respiratory disability, and symptoms now form the new paradigm for assessment of disease severity and guidance of therapeutic strategies. The aim of this review was to explore pathways addressing COPD pathogenesis beyond proximal bronchial obstruction and to highlight innovative and promising tools for phenotyping and bedside assessment. Distal small airways imaging allows quantitative characterisation of emphysema and functional air trapping. Micro-computed tomography and parametric response mapping suggest small airways disease precedes emphysema destruction. Small airways can be assessed functionally using nitrogen washout, probing ventilation at conductive or acinar levels, and forced oscillation technique. These tests may better correlate with respiratory symptoms and may well capture bronchodilation effects beyond proximal obstruction.Knowledge of inflammation-based processes has not provided well-identified targets so far, and eosinophils probably play a minor role. Adaptative immunity or specific small airways secretory protein may provide new therapeutic targets. Pulmonary vasculature is involved in emphysema through capillary loss, microvascular lesions or hypoxia-induced remodelling, thereby impacting respiratory disability.

摘要

慢性阻塞性肺疾病(COPD)的特征是不可逆的近端支气管阻塞,导致严重的呼吸功能障碍。然而,患者表型能更好地捕捉到 COPD 异质性报告的症状和症状。最近的研究提供了证据,表明经典的支气管阻塞不能很好地反映呼吸功能障碍,而症状现在构成了评估疾病严重程度和指导治疗策略的新范式。本综述的目的是探讨解决近端支气管阻塞以外的 COPD 发病机制的途径,并强调用于表型和床边评估的创新和有前途的工具。远端小气道成像允许定量描述肺气肿和功能性空气潴留。微计算机断层扫描和参数响应映射表明小气道疾病先于肺气肿破坏。小气道可以使用氮冲洗、探测传导或腺泡水平的通气以及强迫振荡技术进行功能评估。这些测试可能与呼吸症状更好地相关,并且可能很好地捕捉到近端阻塞以外的支气管扩张作用。基于炎症的过程的知识迄今为止尚未提供明确的靶点,嗜酸性粒细胞可能起次要作用。适应性免疫或特定的小气道分泌蛋白可能提供新的治疗靶点。肺气肿通过毛细血管丧失、微血管病变或缺氧诱导的重塑使肺血管受累,从而影响呼吸功能障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验